{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:50:15Z","timestamp":1785387015141,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018731","name":"Jiangsu Hengrui Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020439","name":"Jiangsu Pharmaceutical Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020439","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jpba.2026.117389","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T07:14:13Z","timestamp":1770016453000},"page":"117389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development and validation of an UPLC\u2013MS\/MS method for simultaneous determination of meropenem and its open-ring metabolite in human serum and cerebrospinal fluid with application to clinical samples"],"prefix":"10.1016","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8405-8919","authenticated-orcid":false,"given":"XiangLong","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2187-8405","authenticated-orcid":false,"given":"Chengliang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1629-5143","authenticated-orcid":false,"given":"Jinwei","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5989-9109","authenticated-orcid":false,"given":"Tongtong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenjia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117389_bib1","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00142-22","article-title":"Plasma and cerebrospinal fluid population pharmacokinetics of meropenem in neurocritical care patients: a prospective two-center study","volume":"66","author":"Kumta","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2026.117389_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00451-24","article-title":"Meropenem pharmacokinetics in cerebrospinal fluid: comparing intermittent and continuous infusion strategies in critically ill patients-a prospective cohort study","volume":"68","author":"Wicha","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.jpba.2026.117389_bib3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2165\/00003495-200868060-00006","article-title":"Meropenem: a review of its use in the treatment of serious bacterial infections","volume":"68","author":"Baldwin","year":"2008","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.jpba.2026.117389_bib4","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/590064","article-title":"Pharmacokinetic and pharmacodynamic properties of meropenem","volume":"47","author":"Nicolau","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jpba.2026.117389_bib5","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13054-016-1523-y","article-title":"Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study","volume":"20","author":"Blassmann","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.jpba.2026.117389_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12941-018-0299-0","article-title":"Cerebrospinal fluid penetration of very high-dose meropenem: a case report","volume":"17","author":"Kerz","year":"2018","journal-title":"Ann. Clin. Microbiol Antimicrob."},{"key":"10.1016\/j.jpba.2026.117389_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jac\/34.1.175","article-title":"Penetration of meropenem into the cerebrospinal fluid of patients with inflamed meninges","volume":"34","author":"Dagan","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2026.117389_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2022.02.017","article-title":"A dosing nomograph for cerebrospinal fluid penetration of meropenem applied by continuous infusion in patients with nosocomial ventriculitis","volume":"28","author":"Konig","year":"2022","journal-title":"Clin. Microbiol Infect."},{"key":"10.1016\/j.jpba.2026.117389_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114900","article-title":"Evaluation of 4 quantification methods for monitoring 16 antibiotics and 1 beta-lactamase inhibitor in human serum by high-performance liquid chromatography with tandem mass spectrometry detection","volume":"219","author":"Seraissol","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117389_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113289","article-title":"HILIC LC-MS\/MS method for the quantification of cefepime, imipenem and meropenem","volume":"186","author":"Rehm","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117389_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116489","article-title":"An LCMS\/MS method for the simultaneous determination of ten antimicrobials and its application in critically ill patients","volume":"252","author":"Liu","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117389_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112973","article-title":"Stability in clinical use and stress testing of meropenem antibiotic by direct infusion ESI-Q-TOF: quantitative method and identification of degradation products","volume":"179","author":"de Souza Barbosa","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117389_bib13","article-title":"The role of non-enzymatic degradation of meropenem-insights from the bottle to the body","volume":"10","author":"Liebchen","year":"2021","journal-title":"Antibiot. (Basel)"},{"key":"10.1016\/j.jpba.2026.117389_bib14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jpba.2017.05.037","article-title":"Therapeutic drug monitoring of beta-lactam antibiotics - Influence of sample stability on the analysis of piperacillin, meropenem, ceftazidime and flucloxacillin by HPLC-UV","volume":"143","author":"Pinder","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117389_bib15","article-title":"Meropenem stability in human plasma at -20 \u00b0 C: detailed assessment of degradation","volume":"10","author":"Gijsen","year":"2021","journal-title":"Antibiot. (Basel)"},{"key":"10.1016\/j.jpba.2026.117389_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27061991","article-title":"Dried plasma spot based lc-ms\/ms method for monitoring of meropenem in the blood of treated patients","volume":"27","author":"Cao","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.jpba.2026.117389_bib17","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1080\/00365513.2022.2137689","article-title":"Therapeutic drug monitoring status of four common antibiotics: vancomycin, meropenem, linezolid and teicoplanin","volume":"82","author":"Zhou","year":"2022","journal-title":"Scand. J. Clin. Lab Invest"},{"key":"10.1016\/j.jpba.2026.117389_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.113944","article-title":"An isotope-dilution LC-MS\/MS method for the simultaneous quantification of meropenem and its open-ring metabolite in serum","volume":"197","author":"Rakete","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117389_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/jac\/27.2.219","article-title":"Pharmacokinetics of meropenem and its metabolite ICI 213,689 in healthy subjects with known renal metabolism of imipenem","volume":"27","author":"Burman","year":"1991","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jpba.2026.117389_bib20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jpba.2019.03.055","article-title":"Stability of meropenem in plasma versus dried blood spots (DBS)","volume":"170","author":"Martens-Lobenhoffer","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117389_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1515\/cclm-2015-0325","article-title":"Effects of biobanking conditions on six antibiotic substances in human serum assessed by a novel evaluation protocol","volume":"54","author":"Zander","year":"2016","journal-title":"Clin. Chem. Lab Med"},{"key":"10.1016\/j.jpba.2026.117389_bib22","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jchromb.2008.09.020","article-title":"Simultaneous determination of three carbapenem antibiotics in plasma by HPLC with ultraviolet detection","volume":"875","author":"Legrand","year":"2008","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2026.117389_bib23","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/chromsci\/bmz087","article-title":"A high-performance liquid chromatographic method for the determination of meropenem in serum","volume":"58","author":"Dincel","year":"2020","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2026.117389_bib24","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1039\/D2AY01459A","article-title":"Triple quadrupole LC\/MS method for the simultaneous quantitative measurement of cefiderocol and meropenem in serum","volume":"15","author":"Riezk","year":"2023","journal-title":"Anal. Methods"},{"key":"10.1016\/j.jpba.2026.117389_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.5301\/ijao.5000377","article-title":"Anti-infective drugs during continuous hemodialysis - using the bench to learn what to do at the bedside","volume":"38","author":"Roehr","year":"2015","journal-title":"Int J. Artif. Organs"},{"key":"10.1016\/j.jpba.2026.117389_bib26","article-title":"Quantification of meropenem in serum and cerebrospinal fluid in children with bacterial meningitis with augmented renal clearance by UPLC-MS\/MS","volume":"10","author":"Jin","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.jpba.2026.117389_bib27","article-title":"Cerebrospinal fluid concentrations of meropenem and vancomycin in ventriculitis patients obtained by TDM-guided continuous infusion","volume":"10","author":"Tiede","year":"2021","journal-title":"Antibiot. (Basel)"},{"key":"10.1016\/j.jpba.2026.117389_bib28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s40262-024-01465-1","article-title":"Population pharmacokinetics of meropenem across the adult lifespan","volume":"64","author":"Boutzoukas","year":"2025","journal-title":"Clin. Pharm."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526000579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526000579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T06:16:13Z","timestamp":1773987373000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526000579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":28,"alternative-id":["S0731708526000579"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117389","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of an UPLC\u2013MS\/MS method for simultaneous determination of meropenem and its open-ring metabolite in human serum and cerebrospinal fluid with application to clinical samples","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117389","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117389"}}